Overview
Angela Leo practices practicing medicine in Florence, Italy.
Her clinical expertise encompasses HER2 Negative Breast Cancer, Osteosarcoma, and Adult Soft Tissue Sarcoma.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Angela D. Leo
Is Angela D. Leo a top-rated expert for HER2 Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Angela D. Leo is classified as an Experienced expert for HER2 Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Angela D. Leo participate in research or clinical trials?
Yes. Angela D. Leo has published 12 articles and abstracts on conditions like HER2 Negative Breast Cancer. You can view a list of Angela D. Leo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue SarcomaMs. Leo isExperienced. Learn about Adult Soft Tissue Sarcoma.
- HER2 Negative Breast CancerMs. Leo isExperienced. Learn about HER2 Negative Breast Cancer.
- OsteosarcomaMs. Leo isExperienced. Learn about Osteosarcoma.